Active, Not Recruiting
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
- Locations
-
- Exelixis Clinical Site #53 Gilbert, Arizona, United States
- Exelixis Clinical Site #18 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Duarte, California, United States
- Exelixis Clinical Site #20 La Jolla, California, United States